Disclaimer: This video is for informational ... Shilpa Medicare: The US FDA issued Form 483 with zero observations for its Raichur-based unit-2. Join us as we analyze these developments, offering ...

The US FDA closed the inspection with zero observations. This is the second consecutive zero 483 inspection at this ... Opala RG for investment purposes. Disclaimer: Business Today provides ...

Aurobindo Pharma received a Form 483 with 11 observations from the USFDA for its Raleigh plant in North Carolina. The company ...

After years of back-and-forth with the FDA over Hetlioz's potential use as a jet lag disorder treatment, Vanda ...

Around 170 workers were cut from the FDA's Office of Inspections and Investigations, according to two federal health officials who were not authorized to speak publicly. "These administrative ...

On Monday, March 31, a court in the Eastern District of Texas found unlawful and vacated the Food and Drug Administration’s ...

All of us have probably had the experience of browsing the aisles at the grocery store looking for healthy foods to take home for our families.  A few foods we find may include the word “healthy” on ...

Exelixis, Inc. EXEL announced that the FDA has approved the label expansion of its lead drug Cabometyx (cabozantinib). The regulatory body approved Cabometyx for the treatment of adult and ...

JPMorgan sees a likely negative impact to Charles River (CRL) after the FDA announced it would be ... recommended by analysts >> Read More on CRL: Disclaimer & Disclosure Report an Issue Charles ...

The justices threw out a lower court's decision that the FDA had failed to follow proper legal procedures under a federal law called the Administrative Procedure Act when it rejected the ...